96.74 0.00 (0.00%)
After hours: 4:32PM EDT
|Bid||95.00 x 200|
|Ask||105.00 x 100|
|Day's Range||95.90 - 98.35|
|52 Week Range||81.43 - 110.67|
|PE Ratio (TTM)||16.45|
|Earnings Date||May 2, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||116.00|
The latest report from the IQVIA™ Institute for Human Data Science found prescription opioid dosage volume — as defined by Morphine Milligram Equivalents (MME) — declined 12 percent in 2017, marking the largest annual drop in more than 25 years of measurement. The study, Medicine Use and Spending in the U.S.: A Review of 2017 and Outlook to 2022, shows that prescription opioid volume had increased annually since 1992, peaking in 2011. Overall, prescription opioid volume decreased annually during the past five years across all 50 states.
IQVIA Holdings Inc. , will announce its first-quarter 2018 financial results before the market opens on Wednesday, May 2, 2018. The IQVIA management team will also host a conference call and webcast at 9:00 a.m.
Founder and former CEO of Quintiles (now Iqvia) Dennis Gillings has retired from the contract research organization's board of directors.
IQVIA Holdings Inc (NYSE:IQV) is trading with a trailing P/E of 16x, which is lower than the industry average of 39.6x. While this makes IQV appear like a great stockRead More...
From BioDelivery Sciences International to Red Hat, insiders at Triangle companies raked in millions in the first three months of 2018, public records show.
Stock Monitor: Psychemedics Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 23, 2018 / Active-Investors.com has just released a free earnings report on IQVIA Holdings Inc. (NYSE: IQV ) ("IQVIA"). ...
One of the top investment conferences, the 2017 Sohn yearly conference gathered hedge funds gurus like David Einhorn or Bill Ackman, who shared some of their investment ideas, and approximately 3,000 attendees. Founded in 1995, the Ira Sohn Conference raises money in support of medical research to help children suffering from cancer and other childhood […]
IQVIA , a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the eyeforpharma conference that it has formed a strategic alliance with MuleSoft, the provider of the leading platform for building application networks.
IQVIA™ , a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, today announced at the eyeforpharma conference that it has entered into an alliance with Box, a leading cloud content management platform provider.
According to a new report from the IQVIA™ Institute for Human Data Science, the types of medicines being developed, the way technology contributes to health, and how the value of health is calculated are all changing dramatically.
Healthcare sector has proven itself to be one of the most resilient sectors of the US economy. Since healthcare cannot be outsourced and represents an expense that people usually cut on last during economic downturns, investing in healthcare stocks is a good way to recession-proof your portfolio. Moreover, the sector itself is comprised of many […]
NEW YORK, Feb. 27, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Mercury ...
New York-area startups and venture capitalists are making funding deals with the hopes of creating the next profitable company. Here's one deal announced Thursday : Who gets : Cota Inc., a healthcare data ...
NEW YORK, Feb. 21, 2018 /PRNewswire/ -- Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (IQV) with major participation by EW Healthcare Partners. Cota will leverage this funding to scale its solutions across healthcare providers, payers and life sciences companies. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include, Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings.
The leading provider of services and data for the life sciences industry posted double-digit gains in revenue and profits.
IQVIA Holdings Inc. , a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients, today reported financial results for the quarter and full-year ended December 31, 2017.
The U.S. Food and Drug Administration on Wednesday approved Biktarvy, Gilead Sciences Inc's once-daily, triple-combination tablet for treatment of HIV infection, paving the way for the biotech company to capture more of the multibillion-dollar HIV drug market. Rival ViiV Healthcare, a joint venture majority-owned by GlaxoSmithKline Plc with Pfizer Inc and Shionogi Ltd, quickly filed a lawsuit alleging that Gilead was infringing patents on ViiV's dolutegravir, a component of the venture's triple-drug HIV treatment Triumeq. Viiv is seeking "financial redress," but is not asking for an injunction against sales of Biktarvy, according to Glaxo spokeswoman Sarah Spencer.
IQVIA Holdings Inc. , a company dedicated to using analytics and science to help healthcare stakeholders find better solutions for patients, is announcing a novel alliance with the FDA Center for Biologics Evaluation and Research to combine advanced analytics and unparalleled information assets to monitor and assist in the evaluation of safety and effectiveness of various CBER-regulated vaccines, blood ...
IQVIA Holdings Inc. , will announce its fourth-quarter and full-year 2017 financial results and issue 2018 guidance before the market opens on Wednesday, February 14, 2018.
Patent expiries and more widespread usage will fuel expected low-to-mid single digit net sales growth in Europe's generic drug market into 2020, says Moody's Investors Service in a report published today. ...
Yahoo Finance's Jared Blikre and Alexis Christoforous break down the latest market action.